Suchergebnisse - "Casper, Corey"

PubPharm (12)

1

Newly diagnosed and previously treated multicentric Castleman disease respond equally to siltuximab

enthalten in: British journal of haematology | 2021

von van Rhee, F. | Rossi, J. | Simpson, D. | +10

2

International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease

enthalten in: Blood advances | 2020

von van Rhee, F. | Oksenhendler, E. | Srkalovic, G. | +26

3

Long-term safety of siltuximab in patients with idiopathic multicentric Castleman disease : a prespecified, open-label, extension analysis of two trials

enthalten in: The Lancet. Haematology | 2020

von van Rhee, F. | Casper, C. | Voorhees, P. | +4

4

The cost effectiveness of treating Burkitt lymphoma in Uganda

enthalten in: Cancer | 2019

von Denburg, A. | Laher, N. | Mutyaba, I. | +5

CommentIn: Cancer. 2019 Jun 1;125(11):1774-1776. - PMID 30840310

5

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

enthalten in: Blood | 2018

von van Rhee, F. | Voorhees, P. | Dispenzieri, A. | +39

CommentIn: Blood. 2018 Nov 15;132(20):2109-2110. - PMID 30442745

6

Whom to treat? Factors associated with chemotherapy recommendations and outcomes among patients with NHL at the Uganda Cancer Institute

enthalten in: PloS one | 2018

von Menon, M. | Coghill, A. | Mutyaba, I. | +5

7

Chemotherapy Use at the End of Life in Uganda

enthalten in: Journal of global oncology | 2017

von Low, D. | Merkel, E. | Menon, M. | +5

8

A phase 2, open-label, multicenter study of the long-term safety of siltuximab (an anti-interleukin-6 monoclonal antibody) in patients with multicentric Castleman disease

enthalten in: Oncotarget | 2015

von van Rhee, F. | Casper, C. | Voorhees, P. | +7

9

Analysis of Inflammatory and Anemia-Related Biomarkers in a Randomized, Double-Blind, Placebo-Controlled Study of Siltuximab (Anti-IL6 Monoclonal Antibody) in Patients With Multicentric Castleman Disease

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2015

von Casper, C. | Chaturvedi, S. | Munshi, N. | +9

10

A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma, multiple myeloma, or Castleman disease

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2013

von Kurzrock, R. | Voorhees, P. | Casper, C. | +14